Navigation Links
Signalling pathways meeting targeting the HER/EGFR family: Focus on breast, lung and colorectal cancers
Date:2/25/2013

The ESMO symposium "Signalling Pathways Targeting the HER/EGFR family in breast, lung and colorectal cancers" is a unique event which will mark the start of a series of events that ESMO will specifically dedicate to issues around the widely debated topic of personalised cancer medicine.

Academic clinical researchers and industry researchers alike will be guided by an extraordinary panel of experts through the challenges and the novelties that the dissection of biomarkers are continuously bringing to the oncology field.

200 attendees are expected from throughout Europe and the rest of the world.

Highlights on:

  • Lively biomarkers: opportunities for liquid biopsy

  • Pitfalls and challenges with tumour tissue specimens

  • Tumour-host interaction: focus on immune response and microenvironment

  • EGFR/HER family targeted therapy in breast, colorectal and lung cancer

  • Adjuvant and neoadjuvant strategies in HER-2/neu breast disease

  • Predictive biomarkers of EGFR inhibition in colorectal cancer: what is there beyond KRAS?

  • Building on EGFR inhibition in lung cancer: Synthetic lethality strategies


'/>"/>

Contact: Press Office
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1

Related biology news :

1. Fragile X and Down syndromes share signalling pathway for intellectual disability
2. Thomas Jefferson University researchers discover new pathways that drive metastatic prostate cancer
3. Long-distance solute transport in trees improved by intercellular pathways in living woody tissues
4. Cleveland Clinic researchers receive $5 million grant to discover novel pathways to heart disease
5. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
6. Insects scientists and children meeting in Las Cruces, New Mexico
7. Meeting: Project aims to predict yield potential to help global food security
8. Press registration open for ASM Biodefense and Emerging Diseases Research Meeting
9. Media invited: Biophysical Society Annual Meeting
10. ACMG 2013 Clinical Genetics Meeting -- Complimentary press registration is now open
11. SSR 2013 Annual Meeting: Call for abstracts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... , November 22, 2016 According to the new ... Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function ... by MarketsandMarkets, the market is expected to grow from USD 10.74 Billion ... of 16.79% between 2016 and 2022. Continue ... ...
(Date:11/17/2016)... -- AIC announces that it has just released a new white paper authored by Zettar ... high speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be ...
(Date:11/14/2016)... , Nov. 14, 2016  Based on ... market, Frost & Sullivan recognizes FST Biometrics ... Award for Visionary Innovation Leadership. FST Biometrics ... biometric identification market by pioneering In Motion ... for instant, seamless, and non-invasive verification. This ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... This report analyzes the worldwide markets for Biostimulants ... Amino, & Fulvic), Extract Based, and Others. The report also ... & Turf, Row Crops, and Others. The report provides separate ... Japan , Europe , ... , and Rest of World. Annual estimates and forecasts are ...
(Date:12/8/2016)... 8, 2016  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... intratumoral cancer immunotherapies, today announced financial results for ... "We are delivering on our commitment to address ... IL-12. We are pleased with the early clinical ... and we are focused on advancing our lead ...
(Date:12/8/2016)... PUNE, India , December 8, 2016 ... is a comprehensive analysis, titled Global Amyloglucosidase Industry 2016 Market ... definition, classification, application, and industry chain overview are all covered ... project SWOT analysis, and investment return analysis of the Amyloglucosidase ... , , ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire-USNewswire/ ... treatments for congestive heart failure and type 2 ... license for a novel adeno-associated virus (AAV) vector ... Kay , M.D., Ph.D., at Stanford University. The ... of its paracrine gene therapy product pipeline. ...
Breaking Biology Technology: